Skip to main content

Home

  • Home
  • Hot
  • New
  • Opinions
  • Media
    • The Times of Israel
    • The Yeshiva World
    • Voz Iz Neias
    • Matzav
  • Home
  • NRx
20 Sep

Though lagging far behind, Israel’s COVID jab aims to ‘find its place in market’

By admin 0 Comments

Chairman of NRx, pharmaceutical company completing trials for BriLife, suggests vaccine may even work better against variants

Vote up!
Vote down!

Points: -13

Hot

  • Mamdani Gains Surprising Hearing from Satmar Leader in NYC Mayoral Race
  • Marine Corps Gunship Helicopter Seen Flying Over Los Angeles
  • MAILBAG: Our Kehilla Is Suffering A Serious Crisis of Basic Mentchlichkeit

User login

  • Create new account
  • Request new password

Recent comments

No comments available.